These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15919650)

  • 21. Is team management appropriate for a patient receiving coronary brachytherapy?
    Jhingran A
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):3. PubMed ID: 12909206
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracoronary radiation therapy for multi-drug resistant in-stent restenosis: initial clinical experience.
    Price MJ; Giap H; Teirstein PS
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):132-4. PubMed ID: 17139654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetry study for beta-radiation treatment of in-stent restenosis.
    Chu CH; Hsieh BT; Chen IJ; Chen WL; Lin UT
    Radiat Prot Dosimetry; 2009 Feb; 134(1):49-54. PubMed ID: 19376885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Too late, too complex, but.
    Bonan R
    J Invasive Cardiol; 2006 Sep; 18(9):440. PubMed ID: 16954588
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug-eluting stents and other anti-restenosis devices].
    Moreno R
    Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches to preventing restenosis.
    Bhargava B; Karthikeyan G; Abizaid AS; Mehran R
    BMJ; 2003 Aug; 327(7409):274-9. PubMed ID: 12896943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose perturbation caused by stents: experiments with a model 90Sr/90Y source.
    Wilczek K; Petelenz B; Strzała A; Marczewska B; Traczyk M; Poloński L
    Cardiovasc Intervent Radiol; 2007; 30(5):981-91. PubMed ID: 17710473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED Study.
    Park SW; Lee SW; Koo BK; Park DW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Mori K; Lansky AJ; Mintz GS; Lee MM; Park SJ
    Int J Cardiol; 2008 Dec; 131(1):70-7. PubMed ID: 18190986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late loss and clinical events.
    Bonan R
    J Invasive Cardiol; 2005 Sep; 17(9):478. PubMed ID: 16145236
    [No Abstract]   [Full Text] [Related]  

  • 31. Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?
    Ruef J; Hofmann M; Störger H; Haase J
    Cardiovasc Revasc Med; 2007; 8(3):170-4. PubMed ID: 17765646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving patient-specific dosimetry for intravascular brachytherapy.
    Li XA; O'Neill M; Suntharalingam M
    Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioactive stents: still in memory?
    Hehrlein C
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):326. PubMed ID: 14988889
    [No Abstract]   [Full Text] [Related]  

  • 34. Ionizing radiation and the coronary arteries: is the plot thickening?
    Schwartz RS
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):282-3. PubMed ID: 15505856
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term outcomes after intracoronary Beta-irradiation for in-stent restenosis in bare-metal stents.
    Maeder MT; Pfisterer ME; Buser PT; Roser HW; Roth J; Weilenmann D; Nietlispach FP; Zellweger MJ; Amsler B; Kaiser CA
    J Invasive Cardiol; 2008 Apr; 20(4):179-84. PubMed ID: 18398235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of absorbable metallic stents with adjunct intracoronary beta radiation in porcine coronary arteries.
    Waksman R; Pakala R; Okabe T; Hellinga D; Chan R; Tio MO; Wittchow E; Hartwig S; Waldmann KH; Harder C
    J Interv Cardiol; 2007 Oct; 20(5):367-72. PubMed ID: 17880333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal treatment for in-stent restenosis after BMS--DES, coated balloon, or scalpel?
    Mukherjee D
    Eur Heart J; 2008 Jul; 29(13):1595-6. PubMed ID: 18556717
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta-radiation as adjuvant treatment of in-stent restenosis in coronary vessels].
    Maeng M; Tanderup K; Jessen KA; Krusell LR; Thuesen L
    Ugeskr Laeger; 2005 Aug; 167(33):3033-6. PubMed ID: 16109245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic miss: what is it?
    Bonan R; Meerkin D; Bertrand O
    J Invasive Cardiol; 1999 Dec; 11(12):749-56. PubMed ID: 10745479
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced level of micronuclei in peripheral blood lymphocytes of patients treated for restenosis with 32P endovascular brachytherapy.
    Wojcik A; Buraczewska I; Sommer S; Brzozowska K; Pregowski J; Witkowski A; Garmol D; Pszona S; Bulski W
    Cardiovasc Revasc Med; 2008; 9(3):149-55. PubMed ID: 18606378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.